SCHEMBL20232193

SCHEMBL20232193

c1ccc(-n2c3ccc(-n4c5ccccc5c5ccccc5c5ccccc5c5ccccc54)cc3c3cc4c(cc32)oc2ccccc24)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.49
ATM Q13315 1/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
AHR P35869 2/20 0.40
MAOA P21397 1/20 0.37
ALDH1A1 P00352 5/20 0.36
MEN1 O00255 4/20 0.36
KMT2A Q03164 4/20 0.36
MAPT P10636 3/20 0.36
SMN1; SMN2 Q16637 3/20 0.36
HPGD P15428 2/20 0.36
PTPN1 P18031 2/20 0.36
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
CYP1A2 P05177 1/20 0.35
POLB P06746 1/20 0.34
TSHR P16473 1/20 0.34
BRCA1 P38398 1/20 0.34
HSD17B10 Q99714 1/20 0.34
PTGER4 P35408 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14822605 0.99 KDM4E (0.50) KDM4EATML3MBTL1AHRMAOA
SCHEMBL16171208 0.96 KDM4E (0.47) KDM4EATML3MBTL1AHRMAOA
SCHEMBL12811614 0.94 KDM4E (0.51) KDM4EATML3MBTL1AHRMAOA
SCHEMBL15946326 0.94 L3MBTL1 (0.55) KDM4EATML3MBTL1AHRALDH1A1
SCHEMBL18381861 0.94 KDM4E (0.55) KDM4EATML3MBTL1AHRMAOA
SCHEMBL17245948 0.93 KDM4E (0.50) KDM4EATML3MBTL1AHRMAOA
SCHEMBL26329809 0.93 KDM4E (0.50) KDM4EATML3MBTL1AHRMAOA
SCHEMBL9890473 0.93 KDM4E (0.50) KDM4EATML3MBTL1AHRMAOA
SCHEMBL16171188 0.93 KDM4E (0.50) KDM4EATML3MBTL1AHRMAOA
SCHEMBL15946288 0.93 KDM4E (0.50) KDM4EATML3MBTL1AHRMAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3548481-B1 HETEROCYCLIC COMPOUNDS FOR USE IN ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2023-08-23 EP disclosed
US-11329233-B2 Heterocyclic compounds for use in electronic devices MERCK PATENT GMBH (DE) 2022-05-10 US disclosed
US-20190296250-A1 HETEROCYCLIC COMPOUNDS FOR USE IN ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2019-09-26 US disclosed
WO-2018100029-A1 HETEROCYCLIC COMPOUNDS FOR USE IN ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2018-06-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190296250-A1 HETEROCYCLIC COMPOUNDS FOR USE IN ELECTRONIC DEVICES NQO1, DDT, ETV6 KDM4E 1555/4885ATM 4662/4885L3MBTL1 3899/4885
US-11329233-B2 Heterocyclic compounds for use in electronic devices NQO1, DDT, ETV6 KDM4E 1555/4885ATM 4662/4885L3MBTL1 3899/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.